Regina Margaret Graul serves as Executive at Cyclerion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Regina Margaret Graul has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 1, 2024 involved receiving (via award) 50,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 1, 2024 | CYCN | $0 | Award | 50,000 | $N/A | Discretionary |
Regina Margaret Graul currently holds 100,303 shares of Cyclerion Therapeutics, Inc. (CYCN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Regina Margaret Graul has been a net neutral trader of CYCN stock. They have purchased $0 and sold $0 worth of shares.
Regina Margaret Graul's most recent insider trade was on Jan 1, 2024, when they sold 50,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted